RISK FACTORS GD is a consequence of autoimmunity against the TSH-R
Acute critical illness: GH-stimulating therapies should generally be avoided during acute illness, major surgery recovery, or trauma, as improved GH in these contexts has been associated with increased mortality in ICU settings
Any compound that potentiates this pathway carries a theoretical risk of promoting neoplastic processes (PMID: 34179015) No Chronic Toxicity Data: Long-term effects of sustained HGF/c-Met potentiation are unstudied even in animal models Uncharacterized Dose-Response: The relationship between Dihexa dose and adverse effects in any living system is poorly defined beyond acute preclinical studies No Regulatory Review: Dihexa has never undergone the systematic safety evaluation required for regulatory submission Safety Comparison Summary: Cerebrolysin has a known, well-characterized safety profile from decades of clinical use
Proper storage is just as important as proper reconstitution to maintain the peptide's potency for the duration of your research
The black box warning on GLP-1 receptor agonists stems from animal studies showing C-cell hyperplasia and medullary thyroid cancer in rodents
Cysteine is one of the amino acids that form the glutathione tripeptide, and methionine helps to synthesize cysteine